宝泰隆新材料股份有限公司 债券募集资金使用管理办法 宝泰隆新材料股份有限公司 公司债券募集资金使用管理办法 第一章 总 则 宝泰隆新材料股份有限公司 债券募集资金使用管理办法 第一条 为了规范宝泰隆新材料股份有限公司（以下简称"公司"）公司债 券募集资金的使用与管理，保护投资者的合法权益，提高募集资金使用效益，根 据《中华人民共和国公司法》、《中华人民共和国证券法》及《公司债券发行与 交易管理办法》等法律法规及规范性文件的相关规定，结合公司实际情况，制定 本办法。 第二条 本办法所称募集资金系指公司（含子公司）通过公开发行和非公开 发行的公司债券（不包括可转换公司债券、分离交易的可转换公司债券）向投资 者募集的资金。 第三条 公司董事会负责建立健全公司募集资金存储、使用和管理的内部控 制制度，在本办法中对募集资金存储、使用、变更、监督和责任追究等内容做出 明确规定。 第四条 公司应按核准或约定的用途使用募集资金，募集资金的使用要履行 公司审批程序。公司应根据相关法律法规的规定，及时披露募集资金使用情况， 履行信息披露义务。 第五条 公司的董事和高级管理人员应当勤勉尽责，督促公司规范使用募集 资金，自觉维护公司 ...

Core Viewpoint - The document outlines the management and usage system for funds raised through bond issuance by Chongqing Zhifei Biological Products Co., Ltd, emphasizing the protection of investors' rights and the efficient use of raised funds [2][4]. Group 1: General Principles - The system is established to regulate the management and use of funds raised through bond issuance, ensuring compliance with relevant laws and regulations [2]. - The term "raised funds" refers to the capital collected from investors through public or private bond issuance [2]. Group 2: Fund Management and Storage - The company must open a special account for the raised funds, ensuring that these funds are managed separately and not mixed with other funds [4][6]. - The company is required to sign a tripartite supervision agreement with the entrusted management institution and the supervising bank before the funds arrive in the special account [4][6]. Group 3: Fund Usage - The company must strictly adhere to the financial management system and the established procedures when using the raised funds [7][8]. - The use of raised funds for non-productive expenditures or to cover losses is prohibited [8]. Group 4: Monitoring and Reporting - The company must continuously monitor the actual management and usage of the raised funds and disclose this information accurately in periodic reports [8][9]. - Any changes to the planned use of raised funds must be approved by the board of directors and disclosed to the entrusted management and bondholders [9]. Group 5: Accountability - Violations of the established system by the company or its executives may result in disciplinary actions, including potential legal consequences [9].